Norway postpones decision on AstraZeneca vaccine By Reuters
OSLO (Reuters) - Norway will take more time to assess whether to resume the use of the AstraZeneca (NASDAQ:AZN) vaccine against COVID-19 or stop it altogether, health minister Bent Hoeie said on Thursday. Norway's Institute of Public Health recommended ending the use of the AstraZeneca vaccine, in line with a Danish decision announced on Wednesday, but the government needs more information before making a final call, the minister said. Norway on March 11 suspended the rollout of the vaccine after a small number of younger inoculated people were hospitalised for a combination of blood clots, bleeding...
Подробнее